4//SEC Filing
Beausang Ellen 4
Accession 0001641172-25-002229
CIK 0000926617other
Filed
Mar 31, 8:00 PM ET
Accepted
Apr 1, 8:59 PM ET
Size
7.8 KB
Accession
0001641172-25-002229
Insider Transaction Report
Form 4
Beausang Ellen
Director
Transactions
- Exercise/Conversion
Common Stock
2025-03-31+1,615→ 1,615 total - Exercise/Conversion
Restricted Stock Units
2025-03-31−1,615→ 4,843 total→ Common Stock (1,615 underlying)
Footnotes (3)
- [F1]Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On March 11, 2025, the reporting person was granted 6,458 RSUs, 1,615 of which vested on March 31, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on April 1, 2025.
- [F2]Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock
- [F3]On March 11, 2025, the reporting person was granted 6,458 RSUs, 1,615 of which vested on March 31, 2025. The common stock into which such vested RSUs converted on March 31, 2025 is reported in Table I on this Form 4.
Documents
Issuer
Aspira Women's Health Inc.
CIK 0000926617
Entity typeother
Related Parties
1- filerCIK 0002061533
Filing Metadata
- Form type
- 4
- Filed
- Mar 31, 8:00 PM ET
- Accepted
- Apr 1, 8:59 PM ET
- Size
- 7.8 KB